UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Sibling Pair with Autosomal Recessive Charcot-Marie-Tooth Disease Due to Novel Ganglioside-induced Differentiation-associated Protein 1 Mutation

Annals of the Indian Academy of Neurology, 2017-10, Vol.20 (4), p.434-435

2017

Volltextzugriff (PDF)

Characteristics and outcomes of 100 consecutive patients with acute stroke and COVID-19

Journal of the neurological sciences, 2021-04, Vol.423, p.117348-117348, Article 117348

2021

Volltextzugriff (PDF)

Cerebral Venous Thrombosis in COVID-19

Neurology India, 2022-03, Vol.70 (2), p.652-659

2022

Volltextzugriff (PDF)

Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase

Bioorganic & medicinal chemistry letters, 2007-12, Vol.17 (24), p.6797-6800

2007

Volltextzugriff (PDF)

Health-related quality of life and associated factors in patients with chronic obstructive pulmonary disease

Drugs & therapy perspectives : for rational drug selection and use, 2019-05, Vol.35 (5), p.241-249

2019

Volltextzugriff (PDF)

Impact of lifestyle modification on glycemic control in patients with type 2 diabetes mellitus

Indian journal of endocrinology and metabolism, 2013-11, Vol.17 (6), p.1030-1039

2013

Volltextzugriff (PDF)

Comparison of case-based learning and traditional lectures in physiology among first year undergraduate medical students

National journal of physiology, pharmacy and pharmacology, 2017, Vol.7 (7), p.1

2017

Volltextzugriff (PDF)

Drug utilization pattern of antiepileptic drugs in a tertiary care teaching rural hospital

National journal of physiology, pharmacy and pharmacology, 2016, Vol.6 (5), p.458

2016

Volltextzugriff (PDF)

The pattern of adverse drug events to antiepileptic drugs: A cross-sectional study at a tertiary care teaching hospital

National journal of physiology, pharmacy and pharmacology, 2016, Vol.6 (6), p.616

2016

Volltextzugriff (PDF)

Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase

Bioorganic & medicinal chemistry letters, 2009-11, Vol.19 (22), p.6404-6412

2009

Volltextzugriff (PDF)

Trends of articles published in National Journal of Physiology, Pharmacy and Pharmacology (NJPPP)

National journal of physiology, pharmacy and pharmacology, 2013, Vol.3 (2), p.111

2013

Volltextzugriff (PDF)

Chronopharmacology: Optimizing drug therapy through biological rhythms

National journal of physiology, pharmacy and pharmacology, 2024-01, Vol.14 (9), p.1732-1738

2024

Volltextzugriff (PDF)

Recent advances in drug therapy for tuberculosis

National journal of physiology, pharmacy and pharmacology, 2024, Vol.14 (5), p.1-814

2024

Volltextzugriff (PDF)

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1' -dioxo-1' 4'-dihydro-1 λ6-benzoll 1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7'-substitution of benzothiadiazine

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1413-1418

2008

Volltextzugriff (PDF)

Pyrrolo[1,2- b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase

Bioorganic & medicinal chemistry, 2008-06, Vol.18 (12), p.3616-3621

2008

Volltextzugriff (PDF)

Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[ b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase

Bioorganic & medicinal chemistry, 2008-07, Vol.18 (14), p.4181-4185

2008

Volltextzugriff (PDF)

Digital therapeutics-a new era in health care

National journal of physiology, pharmacy and pharmacology, 2023, Vol.13 (11), p.1-2196

2023

Volltextzugriff (PDF)

Antimicrobial stewardship program: Fighting antimicrobial resistance in India

National journal of physiology, pharmacy and pharmacology, 2023, Vol.13 (9), p.1-1805

2023

Volltextzugriff (PDF)

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1' ,4'-dihydro-1 λ6-benzoll[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2-and 6-pyridazinone substituents

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1419-1424

2008

Volltextzugriff (PDF)

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'λ6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5. Exploration of pyridazinones containing 6-amino-substituents

Bioorganic & medicinal chemistry letters, 2008-10, Vol.18 (20), p.5635-5639

2008

Volltextzugriff (PDF)

5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase

Bioorganic & medicinal chemistry letters, 2009-01, Vol.19 (2), p.451-458

2009

Volltextzugriff (PDF)

Cost burden of inappropriate peri-operative antibacterial use in a teaching tertiary-care rural hospital in India

Drugs & therapy perspectives : for rational drug selection and use, 2013-08, Vol.29 (8), p.247-252

2013

Volltextzugriff (PDF)

Factors responsible for noncompliance to drug therapy in the elderly and the impact of patient education on improving compliance

Drugs & therapy perspectives : for rational drug selection and use, 2013-11, Vol.29 (11), p.360-366

2013

Volltextzugriff (PDF)

Manipulation of the Membrane Binding Site of Vitamin K-Dependent Proteins: Enhanced Biological Function of Human Factor VII

Proceedings of the National Academy of Sciences - PNAS, 1998-04, Vol.95 (8), p.4229-4234

1998

Volltextzugriff (PDF)

1 – 25 von 768

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(660)
Mit Volltextzugriff
(655)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A Sibling Pair with Autosomal Recessive Charcot-Marie-Tooth Disease Due to Novel Ganglioside-induced Differentiation-associated Protein 1 Mutation

Characteristics and outcomes of 100 consecutive patients with acute stroke and COVID-19

Cerebral Venous Thrombosis in COVID-19

Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase

Health-related quality of life and associated factors in patients with chronic obstructive pulmonary disease

Impact of lifestyle modification on glycemic control in patients with type 2 diabetes mellitus

Comparison of case-based learning and traditional lectures in physiology among first year undergraduate medical students

Drug utilization pattern of antiepileptic drugs in a tertiary care teaching rural hospital

The pattern of adverse drug events to antiepileptic drugs: A cross-sectional study at a tertiary care teaching hospital

Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase

Trends of articles published in National Journal of Physiology, Pharmacy and Pharmacology (NJPPP)

Chronopharmacology: Optimizing drug therapy through biological rhythms

Recent advances in drug therapy for tuberculosis

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1' -dioxo-1' 4'-dihydro-1 λ6-benzoll 1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7'-substitution of benzothiadiazine

Pyrrolo[1,2- b]pyridazin-2-ones as potent inhibitors of HCV NS5B polymerase

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments

Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[ b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase

Digital therapeutics-a new era in health care

Antimicrobial stewardship program: Fighting antimicrobial resistance in India

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1' ,4'-dihydro-1 λ6-benzoll[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2: Variation of the 2-and 6-pyridazinone substituents

Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'λ6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5. Exploration of pyridazinones containing 6-amino-substituents

5,6-Dihydro-1H-pyridin-2-ones as potent inhibitors of HCV NS5B polymerase

Cost burden of inappropriate peri-operative antibacterial use in a teaching tertiary-care rural hospital in India

Factors responsible for noncompliance to drug therapy in the elderly and the impact of patient education on improving compliance

Manipulation of the Membrane Binding Site of Vitamin K-Dependent Proteins: Enhanced Biological Function of Human Factor VII

Suchergebnisse filtern